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Supplementary Figure 1 
Incubation scheme for FUNCAT-PLA and controls for FUNCAT-PLA and Puro-PLA 
(a) Scheme of incubation protocol used to label newly synthesized Camk2a as an exemplar protein, in
cultured hippocampal neurons using AHA. (b) Structure of the biotin alkyne tag Acetylene-PEG4-biotin. (c) 
Upper panel: Full-size images of cells shown in Figure 1b of the main manuscript and additional control 
conditions: leave-out of anti-biotin antibody, methionine instead of AHA in the incubation medium or addition of 
the protein synthesis inhibitor Anisomycin (40 µM) all block the signal. Scale bar = 30 µm. (d) Image showing 
the TGN38 Puro-PLA signal for control conditions without puromycin for the same experiment as shown in 
Figure 1e of the main manuscript. Scale bar = 20 µm. In all images: nuclei stained with DAPI (blue), dendrites 
labeled with an anti-MAP2-antibody (magenta) and the PLA-signal (green). 
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Supplementary Figure 2 
Experimental system to test the FUNCAT-PLA dependence on protein synthesis and coincident presence of
AHA incorporation and the protein of interest 
In these experiments, we optimized the detection of newly synthesized N-Cadherin (NCad) molecules in Lcells, 
which normally do not express cadherins but were stably transfected with Venus-tagged N-Cadherin. (a) 
Western blot showing that NCad-Venus cells express the NCad-Venus fusion protein detected by NCad and 
GFP antibodies, but not endogenous NCad. Lcells express neither NCad nor GFP (Venus). (b) Images of 
Lcells expressing NCad-Venus (left, Venus fluorescence in green) and wild type (WT) Lcells lacking NCad-
Venus expression (nuclei are labeled with DAPI (blue) and the Venus fluorescence is shown in grayscale
image in white). Scale bar = 30 µm. (c) Images of anti-N-Cadherin immunocytochemical labeling (red) and 
Venus fluorescence (green) in a mixed population of WT and NCad-Venus-expressing Lcells. Only cells
expressing NCad-Venus show positive antibody labeling for NCad. Scale bar = 30 m. (d) Images of mixed 
cell populations treated with AHA (4 mM for 2 h) followed by click-chemistry for fluorescent detection of newly 
synthesized proteins (FUNCAT) resulted in robust signal in the entire (transfected and non-transfected) 
population of Lcells (d, upper panel). In contrast, methionine (Met)-treatment led to negligible FUNCAT signal 
in the population (d, lower panel). Scale bar = 30 m. (e) Images of mixed cell populations with labeling of the 
total amount of either NCad-Venus or biotin (AHA) using single antibody PLA. Scale bar = 50 µm. To detect 
(and titrate) a single antibody, PLAplus and PLAminus probes against the same species are applied. 
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Supplementary Figure 3 
Selectivity and specificity of labeling newly synthesized proteins
To show the dependence of FUNCAT-PLA on the coincident presence of both partners and on protein
synthesis we combined the detection of NCad-Venus and newly synthesized molecules following 2 h of AHA 
treatment in a mixed population using an antibody to Venus (GFP) and one to biotin. (a) FUNCAT-PLA labeling 
strategy. (b) Images of mixed populations with abundant newly synthesized NCad-Venus (green) in AHA-
treated cells (upper panel) but not in Met-treated cells (middle panel) or in presence of Anisomycin (lower 
panel). Using the endogenous Venus fluorescence (red) as a marker to localize transfected cells we found that
within the mixed population of AHA-treated cells, the coincidence PLA signal was detected exclusively in the
transfected cells (b-1), not in wild type (WT) cells (b-2). Thus, the coincidence detection system indeed led to
significant labeling only when both parts – newly synthesized proteins and the protein of interest - were 
present. Scale bar = 50 m; 10 m in inset. (c,d) Quantification of the signal in both the biological
(untransfected WT cells, Met, AHA/Aniso) and technical (omission of one primary antibody) controls using the
NCad-biotin (c) or the GFP-biotin combination of primary antibodies (d). Signals are normalized to the mean 
signal in AHA-treated NCadVenus-expressing cells and shown as mean ± SEM resulting from two - four
independent experiments (c: n = 66 - 133, d: n = 8 - 12). All control group values were significantly lower than
the values in AHA-treated NCad-Venus cells (ANOVA, Tukey's multiple comparisons test. ***P < 0.0001). 
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Supplementary Figure 4 
Pulse-labeling followed by FUNCAT-PLA reveals distinct spatial patterns for newly synthesized protein species
in neurons 
Images showing total protein labeling by immunostaining for a variety of example proteins in hippocampal
neurons (left double panel) as fluorescence image overlay (left; POI = green) with anti-MAP2 (red) and nuclei 
stained with DAPI (blue) or the POI channel converted to grey scale for better visualization (right). In the right
double panel the corresponding FUNCAT-PLA signal for the same POI in cells treated with AHA (2 h; 15 min
chase; AHA panel) or without AHA (Met panel) are displayed. Cells were processed using FUNCAT-PLA with 
antibodies against the indicated proteins of interest and images converted to representations on white
background for better visualization. Close-ups for Bassoon, LaminB and TGN38 are shown in Figure 1 of the 
main manuscript. Scale bar = 30 m, MAP2 outline grey, PLA signal red, DAPI blue. 
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Supplementary Figure 5 
Bassoon FUNCAT-PLA signal is present in axons, and comparison of Puro-PLA and single-antibody PLA for 
bassoon 
(a) Images of a neuron showing that pulse-labeled Bassoon is present in axons and accounts for signal that
does not overlap with the MAP2-positive somato-dendritic area. Left: merged image of FUNCAT-PLA signal for 
Bassoon (green), axonal staining (anti-neurofilament Smi312 monoclonal, blue) and dendrites (anti-MAP2, 
red); nuclei are visualized with DAPI (blue). Arrows indicate examples of sites at which the Bassoon FUNCAT-
PLA signal colocalizes with the axonal marker. Hippocampal neurons were labeled with AHA for 2 h and 
chased for 10 min before performing FUNCAT-PLA labeling. Scale bar = 20 µm. (b) Graph of the comparison 
of the ratio of integrated signal intensity for Puro-PLA and single antibody-PLA (total) for the N-terminal and C-
terminal Bassoon antibody signals. The Puro-PLA N-term to C-term ratio is higher than the total N-term to C-
term ratio. For total epitope measurements two independent experiments were performed with n = 7 cells per 
condition. 
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Supplementary Figure 6 
Incubation scheme and controls for GluA1 FUNCAT-PLA 
(a) Graph as shown in main Figure 3d without the x-axis scale change and interruption (distributional changes 
of Bassoon FUNCAT-PLA signal with chase time). (b) Incubation scheme used to metabolically label 
hippocampal neurons with AHA and compare newly synthesized GluA1 levels with and without induction of
homeostatic plasticity and corresponding methionine and protein synthesis inhibitor controls. (c) GluA1 
FUNCAT-PLA (green) example images for methionine and protein synthesis inhibitor controls from the same
experiment as shown in Figure 3e. Dendrites stained with anti-MAP2 (magenta). Scale bar = 20 µm. 
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Supplementary Figure 7 
Influence of methionine starvation on Puro-PLA labeling 
(a) To assess if there is a strong influence of methionine starvation on protein synthesis we performed a Puro-
PLA experiment for TGN38 with (– Met) and without (+ Met) incubation in methionine-free Neurobasal A (30 
min) prior to a 15 min puromycylation and processing for TGN38 Puro-PLA. No difference was detected in the 
Puro-PLA signal suggesting that the influence is not substantial under these conditions. Data is displayed as
box plot with median and minimum and maximum. Two independent experiments were analysed with n = 42 -
43 cells. 
 
Supplementary Table 1 
 
 Puro-PLA FUNCAT-PLA 
Incorporation Fast  Slow 
 No activation required Uptake by amino acid transporter and activation by MetRS 
needed 
 Competition with all activated tRNAs Competition with methionine 
 Labeling in full conditioned medium Labeling in methionine-free medium 
 No starvation necessary Methionine starvation conditions promote labeling (either with 
pre-starvation or at least during incubation) 
 C-terminal incorporation, possible at any site but 
limited to one Puromycin per protein 
Only replacement of methionine residues possible, more than 
one methionine replacement possible per protein 
Protein Full labeling (= one puromycin per protein) would 
lead to protein synthesis block 
Full labeling in theory possible 
 Truncated, premature termination of labeled 
protein 
Full length protein with small bio-orthogonal groups 
 Enhanced degradation/ turnover of truncated 
proteins expected, non-physiological protein fate 
Physiological fate  
Method 
characteristics 
Fast, sensitive Lag phase, especially when used without methionine 
starvation, less sensitive than Puro-PLA 
 Short labeling, unlikely to influence short term 
physiology 
Labeling conditions might impact short term physiology, but 
also see Supplementary Figure 7 
 Puro antibodies needed 
N-terminal POI antibodies are predicted to work 
better than C-terminal 
Biotin antibodies needed 
 
  Additional step required (biotin click) 
 Estimating intra- vs intermolecular detection with 
N-/C-term antibody against POI possible 
Modification by direct click of a PLA oligo possible 
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Recommended 
method use 
Short term measurements 
Site of synthesis 
Synthesis rate at a time point 
Long term measurements  
Turnover 
Half life 
Distribution changes 
Synthesis in time interval 
 
Nature Methods: doi:10.1038/nmeth.3319
